Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study

Hebert Alberto Vargas; Gem M. Kramer; Andrew M. Scott; Andrew Weickhardt; Andreas A. Meier; Nicole Parada; Bradley J. Beattie; John L. Humm; Kevin D. Staton; Pat B. Zanzonico; Serge K. Lyashchenko; Jason S. Lewis; Maqsood Yaqub; Ramon E. Sosa; Alfons J. van den Eertwegh; Ian D. Davis; Uwe Ackermann; Kunthi Pathmaraj; Robert C. Schuit; Albert D. Windhorst; Sue Chua; Wolfgang A. Weber; Steven M. Larson; Howard I. Scher; Adriaan A. Lammertsma; Otto S. Hoekstra; Michael J. Morris

doi:10.2967/jnumed.117.206490

Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study

Journal of Nuclear Medicine ◽

10.2967/jnumed.117.206490 ◽

2018 ◽

Vol 59 (10) ◽

pp. 1516-1523 ◽

Cited By ~ 3

Author(s):

Hebert Alberto Vargas ◽

Gem M. Kramer ◽

Andrew M. Scott ◽

Andrew Weickhardt ◽

Andreas A. Meier ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Castration Resistant Prostate Cancer ◽

Prospective Multicenter Study ◽

Castration Resistant ◽

Cancer Metastases

Download Full-text

A prospective multicenter study of intermittent chemotherapy with docetaxel and prednisolone for castration-resistant prostate cancer

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyw021 ◽

2016 ◽

Vol 46 (6) ◽

pp. 547-553 ◽

Cited By ~ 3

Author(s):

Shintaro Narita ◽

Takuya Koie ◽

Shigeyuki Yamada ◽

Kazuhiko Orikasa ◽

Shigeki Matsuo ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Castration Resistant Prostate Cancer ◽

Prospective Multicenter Study ◽

Castration Resistant ◽

Intermittent Chemotherapy

Download Full-text

MP87-11 INTRINSIC PROSTATE CANCER SUBTYPES DETERMINED IN DIAGNOSTIC PROSTATE BIOPSIES OF MEN WITH METASTATIC DISEASE RESEMBLE CASTRATION-RESISTANT PROSTATE CANCER METASTASES

The Journal of Urology ◽

10.1016/j.juro.2017.02.2715 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Eric Miller ◽

Sungyong You ◽

Lorna Kwan ◽

Xinmin Li ◽

Michael Lewis ◽

...

Keyword(s):

Prostate Cancer ◽

Metastatic Disease ◽

Castration Resistant Prostate Cancer ◽

Cancer Subtypes ◽

Prostate Biopsies ◽

Castration Resistant ◽

Cancer Metastases

Download Full-text

Switch from prednisone to dexamethasone in patients with metastatic castration resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) in a multicenter study

European Urology Supplements ◽

10.1016/s1569-9056(19)34626-3 ◽

2019 ◽

Vol 18 (11) ◽

pp. e3464

Author(s):

I. Rivero Belenchón ◽

C. Muñoz Calahorro ◽

I. Osmán García ◽

P. Beardo Villar ◽

C.B. Congregado Ruíz ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Prognosis of metastatic castration‐resistant prostate cancer in the era of the second‐generation androgen receptor‐targeted agents: A retrospective multicenter study

International Journal of Urology ◽

10.1111/iju.14392 ◽

2020 ◽

Author(s):

Hiromichi Iwamura ◽

Shingo Hatakeyama ◽

Shintaro Narita ◽

Yoichi Arai ◽

Tomonori Habuchi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Multicenter Study ◽

Second Generation ◽

Targeted Agents ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Retrospective Multicenter Study

Download Full-text

A transcriptome analysis of castration resistant prostate cancer metastases in a prospective cohort study reveals high expression of AKT pathway genes predictive of long term response to abiraterone acetate/prednisone.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5038 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5038-5038 ◽

Cited By ~ 1

Author(s):

Manish Kohli ◽

Scott Dehm ◽

Vipul Bhargava ◽

Michael Gormley ◽

Jason P. Sinnwell ◽

...

Keyword(s):

Prostate Cancer ◽

Cohort Study ◽

Transcriptome Analysis ◽

Abiraterone Acetate ◽

Akt Pathway ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Cancer Metastases ◽

Term Response

Download Full-text

Saikosaponin-d: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2016.05.017 ◽

2016 ◽

Vol 474 (4) ◽

pp. 722-729 ◽

Cited By ~ 13

Author(s):

Di Zhong ◽

Hui-jian Zhang ◽

Yao-dong Jiang ◽

Peng Wu ◽

Huan Qi ◽

...

Keyword(s):

Prostate Cancer ◽

Stem Cell ◽

Cancer Stem Cell ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Cancer Metastases ◽

Cell Phenotypes

Download Full-text

Switching from prednisone to dexamethasone in metastatic castration resistant prostate cancer treated with abiraterone acetate in a multicenter study

European Urology Open Science ◽

10.1016/s2666-1683(20)33180-3 ◽

2020 ◽

Vol 19 ◽

pp. e897-e898

Author(s):

I. Rivero Belenchón ◽

C. Muñoz Calahorro ◽

I. Osmán García ◽

P. Beardo Villar ◽

C.B. Congregado Ruíz ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

British Journal of Cancer ◽

10.1038/s41416-018-0172-0 ◽

2018 ◽

Vol 119 (3) ◽

pp. 347-356 ◽

Cited By ~ 18

Author(s):

Heini M. L. Kallio ◽

Reija Hieta ◽

Leena Latonen ◽

Anniina Brofeldt ◽

Matti Annala ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variants ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Cancer Metastases ◽

Androgen Receptor Splice Variants ◽

Constitutively Active

Download Full-text

Abstract 1802: Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

10.1158/1538-7445.am2018-1802 ◽

2018 ◽

Cited By ~ 1

Author(s):

Heini M. Kallio ◽

Reija Hieta ◽

Anniina Brofeldt ◽

Matti Annala ◽

Kati Kivinummi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variants ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Cancer Metastases ◽

Androgen Receptor Splice Variants ◽

Constitutively Active

Download Full-text

Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy: PREMIERE-SOGUG Trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps5073 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS5073-TPS5073

Author(s):

Enrique Grande ◽

Enrique Gonzalez-Billalabeitia ◽

Ignacio Duran ◽

Carmen Santander ◽

Enrique Gallardo Diaz ◽

...

Keyword(s):

Prostate Cancer ◽

Blood Sample ◽

Phase Ii ◽

Multicenter Study ◽

Predictive Value ◽

Fusion Gene ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text